Drug recall
Premarin Tablets (conjugated estrogens tablets, USP) 0.625 mg, unit dose packages of 100, and bottles of 100…
FDA recall event 25230 · Class III · Amerisource Health Services Corp
Key facts
| Event ID | 25230 |
|---|---|
| Recall numbers | D-102-3 |
| Recalling firm | Amerisource Health Services Corp |
| Product type | Drugs |
| Products | Premarin Tablets (conjugated estrogens tablets, USP) 0.625 mg, unit dose packages of 100, and bottles of 100 and 1000 count, Rx only, Mfg by: Ayerst Laboratories Inc., A Wyeth-Ayerst Company… |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Dissolution; failure to meet specifications by manufacturer (Wyeth) |
| Initiation date | Dec 17, 2002 |
| City | Columbus |
| Country | United States |
| FEI number | 3000209995 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports